Showing results (471-480 of 612) with videos related to
Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 17, 2022
The use of OCT in good visual acuity MOGAD and AQP4-NMOSD patients; with and without optic neuritisA Roca-Fernández, V Camera, G Loncarevic-Whitaker, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
A multisite randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Very long term (5-6 year) follow-up at one siteJulia Norton, Sandra Joos, Michelle H Cameron, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Cardiorespiratory fitness and moderate-to-vigorous physical activity in older adults with multiple sclerosisRobert W Motl, Jessica F BairdMultiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)Silvy Pilotto, Jessica Gencarelli, Stefania Bova, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 12, 2022
Fingolimod versus interferon beta 1-a: Benefit-harm assessment approach based on TRANSFORMS individual patient dataAlessandra Spanu, Hélène E Aschmann, Jürg Kesselring, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 24, 2021
The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomideStanley Cohan, Tiffany Gervasi-Follmar, Aneesh Kamath, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Usefulness of two-dimensional measurements for the evaluation of brain volume and disability in multiple sclerosisSatori Ajitomi, Juichi Fujimori, Ichiro NakashimaMultiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha InhibitorShin Yee Chey, Allan G KermodeMultiple Sclerosis Journal - Experimental, Translational and Clinical|October 18, 2018
Real-world experience of fingolimod in patients with multiple sclerosis (MS Fine): An observational study in the UKGordon Mazibrada, Charlotte Sharples, Ines PerfectMultiple Sclerosis Journal - Experimental, Translational and Clinical|April 28, 2022
The socioeconomic impact of multiple sclerosis in France: Results from the PETALS studyA Bouleau, C Dulong, C A Schwerer, et al.Pageof 62